In December 19 2015, the thanks meeting for the being listed of Zhuhai Encode Medical Engineering Co., Ltd. (833787) is held in Zhuhai Resort Hotel. In the meeting, hundreds of people from the national association of health industry and enterprises management, Zhuhai local governments, Dongguan securities, banks and other institutions comes to the meeting. They are here to celebrate Zhuhai Encode’s being listed and talk about the future development.

Zhuhai Encode Medical Engineering Co., Ltd. was founded in May 30, 2006. After ten years of accumulation, it has successfully been listed in National Equities Exchange and Quotations (NEEQ) in only 8 months in 2015 and becomes the first IVD enterprise in Zhuhai that has been listed.

In the thanks meeting, Zhuhai Encode CEO Sun Yifeng, Song Haibo from CACLP, Zhou Xiaodong from Zhuhai food and drug administration, Li Haiqing from Zhuhai Jinwan District CPPCC, Xu Fengmei from Zhuhai Municipal Finance Bureau, Xu Fengmei from the town party of Hongqi town, He Qingjian from Dongguan securities co., LTD., Guilin Uritest group CEO Zheng Zehui gave speeches and talked about the future development of Zhuhai Encode.

Yifeng Sun, Chairman of Encode medical, said in the speech that from ten years development of Encode medical to now successfully listing on the stock market, it owes a lot to the leaders in the government, friends and partners. By making full use of the opportunity of the rapid development of China's health industry, public financing and leveraging the capital market, Encode medical will start mergers and acquisitions in upstream or downstream and similar industries, and increase a variety of ways of product development, production and marketing. By working together with new and old partners, they can compose a more magnificent chapter in the future!

(Construction Bank of Zhuhai Branch credits 200 million yuan to Encode medical. The picture is when they sign the strategic cooperation agreement. Left is the Yifeng Sun, General Manager of Encode medical. Right is Chongxiang He, Vice President of China Construction Bank of Zhuhai branch.)

In order to help all the guests present have a deeper understanding of Encode medical, the senior management team of the company have introduced the direction of future R & D projects of the company, quality control system, financial management practices and marketing strategic planning to them in the following session. Part of the business partners also made a speech in the scene, sharing the experiences of deep friendship and win-win cooperation with Encode medical. They congratulated the successful listing of Encode medical and believed that Encode medical will be better and better.

After the meeting, cooperative clients were invited to visit the production base of Encode medical, and they also communicated and interacted with the project managers. They knew well MicroDst susceptibility testing of Mycobacterium microplate reagents that the company has currently gotten listed and on the new push, as well as the “stomach prophet” Helicobacter pylori self-test card suitable for personal and family self-detect. They spoke highly of the highlights, advantages and market prospects of the two new products, and showed strong cooperation intention.